Soluble Adhesion Molecules in Gastric Cancer
Author Information
Author(s): G Velikova, RE Banks, A Gearing, I Hemingway, MA Forbes, SR Preston, M Jones, J Wyatt, K Miller, U Ward, J Al-Maskattil, SM Singh, NS Ambrose, JN Primrose, PJ Selby
Primary Institution: ICRF Cancer Medicine Research Unit, St James's University Hospital
Hypothesis
The study investigates the concentrations of soluble adhesion molecules in patients with gastric cancer and their correlation with clinical parameters.
Conclusion
Elevated levels of soluble ICAM-1 and VCAM-1 are associated with advanced gastric cancer and poorer survival.
Supporting Evidence
- Serum concentrations of ICAM-1 and VCAM-1 were significantly elevated in gastric cancer patients compared to healthy subjects.
- Increased VCAM-1 levels were associated with locally advanced and metastatic disease.
- Patients with elevated VCAM-1 had significantly poorer survival compared to those with normal levels.
Takeaway
Doctors looked at certain proteins in the blood of stomach cancer patients to see if they could tell how serious the cancer was. They found that higher levels of some proteins meant worse outcomes.
Methodology
Blood samples were taken from patients with gastric cancer before treatment, and levels of soluble adhesion molecules were measured using ELISA kits.
Potential Biases
The study's findings may be influenced by the small sample size and missing data on tumor pathology.
Limitations
The study had missing data on grading of differentiation, inflammation, and ulceration due to the independent review being performed only on surgical specimens.
Participant Demographics
Median age of participants was 73 years, with 15 females and 30 males.
Statistical Information
P-Value
P=0.0361
Statistical Significance
p<0.00001
Want to read the original?
Access the complete publication on the publisher's website